PHILHELDEX(Cefdinir 300mg)

Cefdinir is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions such as (1) Community-Acquired Pneumonia which is caused by Haemophilus influenzae (including ß-lactamase producing strains), Haemophilus parainfluenzae (including ß-lactamase producing strains), Streptococcus pneumoniae (penicillin-susceptible strains only) and Moraxella catarrhalis (including ß lactamase producing strains). (2) Acute Exacerbations of Chronic Bronchitis which is caused by Haemophilus influenzae (including ß-lactamase producing strains), Haemophilus parainfluenzae (including ß-lactamase producing strains), Streptococcus pneumoniae (penicillin-susceptible strains only) and Moraxella catarrhalis (including ß lactamase producing strains). (3) Acute Maxillary Sinusitis which is caused by Haemophilus influenzae (including ß-lactamase producing strains), Streptococcus pneumoniae (penicillin-susceptible strains only) and Moraxella catarrhalis (including ß-lactamase producing strains). (4) Pharyngitis / Tonsillitis which is caused by Streptococcus pyogenes. (5) Uncomplicated Skin and Skin Structure Infections which is caused by Staphylococcus aureus (including ß-lactamase producing strains) and Streptococcus pyogenes; Dosage: The total daily dose for all infections is 600 mg. Cefdinir may be taken without regard to meals; Package: 3 x 10Bl , 10 x 10Bl .